Launched in June 2021 by three founding members (AstraZeneca, Docaposte and Impact Healthcare), the AgorIA Santé consortium aims at bringing together research stakeholders to facilitate the analysis of real-life health data for public health purposes. AgorIA Santé thus offers a secure technological platform for hosting and analysing health data...Read
The “Life sciences” department works with companies involved in health and medical technologies, as well as their partners, at all steps in the lives of their products, as part of their development, pre-clinical or clinical assessment, valuation of innovations, marketing, reimbursement or distribution.
The department’s team also advises health establishments of any form, as well as companies and organisations in this sector, relative to their relations with health professionals. For certain customers, it provides outsourced management of the procedures relative to the implementation of these contractual relations.
The lawyers in the “Life sciences” department are distinguished by the particular assistance that they provide to their clients during inspections performed by health authorities, and as part of the defence of their interests in the event of administrative or judicial disputes.
Moreover, faced with the development of digital technology that’s now leading to a true “datafication” of our societies, the definition of a strategy for optimal data management and exploitation is becoming a major concern for all actors in the health sector.
Knowledge and familiarity with the legal and functional framework by actors and the role that they play in health information systems regardless of the objective – management of medical files, research files, medical-social monitoring, hosting, etc. – are essential for everyone involved in today’s health sector.
The “Life sciences” department works with you on the following subjects :
- assistance with the regulatory framework for projects involving health information systems (tele-medicine, health cooperation consortia, territorial hospital groups, etc.),
- assistance with understanding the new rules for exchanges and sharing of health data within the health sector and within the medical-social sector, drafting of hosting contracts for health data and coordination of the various required authorisations,
- consultations on the conditions for accessing health data (including Big data issues), etc.
The department’s members provide extensive inter- and intra-company training in the areas of clinical research, health data, administrative inspections, the usage of biological samples, health products, the valuation of innovations, regulatory compliance, etc.
Given the cross-disciplinary nature of many files entrusted to the “Life sciences” department, and in order to respond to the range and complexity of issues arising for the actors in this sector, these files are handled in close collaboration with the firm’s other departments, primarily the “Personal data”, “Corporate law – Mergers-acquisitions”, “Non-profit organisations”, “Public law” and “Disputes” departments.
The team works in French or English.
Rankings of the department
- LEGAL 500 EMEA 2022
- in Tier 4 in Health care & life sciences
- PALMARES DU DROIT 2022
- (Paris) – Life sciences : Bronze Trophy
- DECIDEURS 2022
- Health, pharmacy and biotechnologies – Electronic health : Unbeatable
- Health, pharmacy and biotechnologies – Advice to health care institutions - hospital cooperation : Excellent
- PALMARES DU DROIT 2021
- (Lyon) - Life sciences : Bronze Trophy
- (Lyon) - Life sciences : Bronze Trophy
DELSOL Avocats is proud to be ranked in 9 Legal 500 EMEA 2022 categories : Construction – Tier 3 Data privacy and data protection – Tier 3 Dispute resolution : White-collar crime – Tier 4 Employment – Tier 4 Industry focus : Healthcare and life sciences – Tier 4 Mergers and acquisitions – Tier 5 Private equity : venture/growth...Read
Gaëlle Merlier is joining the DELSOL Avocats Life Sciences practice as a partner accompanied by associate Bastien Pavec, who worked alongside her at Clifford Chance. The Life Sciences team, led by another specialist in the sector, Jeanne Bossi Malafosse, now has two partners and four associates. They assist their clients, health and medical...Read
AstraZeneca, Docaposte and Impact Healthcare have created the « Agoria Santé » consortium to provide public and private players with a controlled legal framework and shared governance to carry out research projects on health data. The consortium offers a secure platform for hosting and analyzing health data. The consortium’s health data warehouse...Read